8-K: Scorpius Holdings Faces Delisting from NYSE American and Director Resignation
8-K Filing
Scorpius Holdings, Inc. will be delisted from the NYSE American after deciding not to appeal the decision, and a director, John Prendergast, Ph.D., has resigned effective immediately.
Summary
- Scorpius Holdings, Inc. received notice from the NYSE Regulation on April 21, 2025, that trading of its common stock was suspended and delisting proceedings would commence due to the low selling price of the stock.
- Trading on the NYSE American was suspended after market close on April 21, 2025, and began trading on the OTC Market on April 22, 2025.
- The company decided not to appeal the NYSE American's delisting determination on April 28, 2025.
- The NYSE American filed a Form 25 with the SEC on May 1, 2025, to delist the company's common stock, with the delisting becoming effective ten days after the filing.
- Scorpius Holdings will remain a reporting entity under the Securities Exchange Act of 1934.
- On May 2, 2025, John Prendergast, Ph.D., resigned from the Board of Directors, effective immediately.
- Mr. Prendergast did not express any disagreement with the company regarding its operations, policies, or practices.
Sentiment
Score: 2
Explanation: The news of delisting and a director's resignation is generally negative for the company's prospects.
Negatives
- Scorpius Holdings' common stock is being delisted from the NYSE American.
- A director, John Prendergast, Ph.D., has resigned from the Board of Directors.
Risks
- Delisting from the NYSE American could negatively impact investor confidence and the company's stock price.
- The resignation of a director could create a temporary void in leadership and oversight.
Future Outlook
The Company will remain a reporting entity under the Securities Exchange Act of 1934, as amended, with respect to continued disclosure of financial and operational information.
Industry Context
Delistings can occur for various reasons, including failure to meet minimum listing requirements, such as maintaining a minimum stock price. Director resignations can be triggered by a variety of factors, including disagreements with company strategy or personal reasons.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | John Prendergast, Ph.D. | May 2, 2025 | Resignation |
Stakeholder Impact
- Shareholders may experience a decrease in the value of their investment due to the delisting.
- Employees may experience uncertainty about the company's future.
- The company's reputation may be negatively impacted.
Key Dates
| Date | Description |
|---|---|
| April 21, 2025 | Scorpius Holdings received notice of delisting from NYSE Regulation and trading was suspended after market close. |
| April 22, 2025 | Trading began on the OTC Market. |
| April 28, 2025 | The Company decided not to appeal NYSE American's determination to delist the Company's common stock. |
| May 1, 2025 | NYSE American filed a Form 25 with the SEC to delist the company's common stock. |
| May 2, 2025 | John Prendergast, Ph.D., resigned from the Board of Directors, effective immediately. |
Keywords
delisting, NYSE American, resignation, common stock, Scorpius Holdings, director, OTC Market
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.